Matthew Campbell, MD, MS

Matthew Campbell, MD, MS, University of Texas MD Anderson Cancer Center

Articles by Matthew Campbell, MD, MS

UNITE Study: Outcomes With SG for Patients with Variant Histologies

Vadim Koshkin, MDUrothelial Carcinoma | February 12, 2024

The outcomes related to sacituzumab govitecan for patients with variant histologies are highlighted.

UNITE Study: Sequencing Erdafitinib and EV for Patients With FGFR2/3-Altered Disease

Vadim Koshkin, MDAdvanced Urothelial Carcinoma | May 20, 2024

The potential for sequencing erdafitinib and EV for patients with FGFR2/3-altered disease is considered.

UNITE Study: Impact of Squamous, Other Histologies on Outcomes With EV

Vadim Koshkin, MDAdvanced Urothelial Carcinoma | May 20, 2024

The impact of squamous and other histologies on outcomes with EV are dissected.

UNITE Study: Design, Patients Sampled, and Outcomes With EV After Switch Maintenance Avelumab

Vadim Koshkin, MDAdvanced Urothelial Carcinoma | May 20, 2024

The design of UNITE, patients sampled, and outcomes with EV after switch maintenance avelumab are explored.